Hatano, Taku

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Bril, V., Drużdż, A., Grosskreutz, J., Habib, A. A., Mantegazza, R., Sacconi, S., Utsugisawa, K., Vissing, J., Vu, T., Boehnlein, M., et al. (2023) · The Lancet Neurology

Myasthenia Gravis and ThymomaPeripheral Neuropathies and Disorders

Cited by 295

Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease

Kamagata, K., Hatano, T., Okuzumi, A., Motoi, Y., Abe, O., Shimoji, K., Kamiya, K., Suzuki, M., Hori, M., Kumamaru, K. K., et al. (2016) · European Radiology

Advanced Neuroimaging Techniques and ApplicationsParkinson's Disease Mechanisms and Treatments

Cited by 135

Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease

Oji, Y., Hatano, T., Ueno, S.-I., Funayama, M., Ishikawa, K.-I., Okuzumi, A., Noda, S., Sato, S., Satake, W., Toda, T., et al. (2020) · Brain

Parkinson's Disease Mechanisms and TreatmentsLysosomal Storage Disorders Research

Cited by 116

Gray Matter Abnormalities in Idiopathic Parkinson's Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging

Kamagata, K., Zalesky, A., Hatano, T., Ueda, R., Di Biase, M. A., Okuzumi, A., Shimoji, K., Hori, M., Caeyenberghs, K., Pantelis, C., et al. (2017) · Human Brain Mapping

Advanced Neuroimaging Techniques and ApplicationsParkinson's Disease Mechanisms and Treatments

Cited by 106

Neurite orientation dispersion and density imaging of the nigrostriatal pathway in Parkinson’s disease: retrograde degeneration observed by tract-profile analysis

Andica, C., Kamagata, K., Hatano, T., Okuzumi, A., Saito, A., Nakazawa, M., Ueda, R., Motoi, Y., Kamiya, K., Suzuki, M., et al. (2018) · Parkinsonism & Related Disorders

Advanced Neuroimaging Techniques and ApplicationsParkinson's Disease Mechanisms and Treatments

Cited by 60

Anhedonia and its correlation with clinical aspects in Parkinson’s disease

Nagayama, H., Maeda, T., Uchiyama, T., Hashimoto, M., Nomoto, N., Kano, O., Takahashi, T., Terashi, H., Hamada, S., Hasegawa, T., et al. (2017) · Journal of the Neurological Sciences

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 33

Neurocognitive and psychiatric disorders‐related axonal degeneration in Parkinson’s disease

Andica, C., Kamagata, K., Hatano, T., Saito, Y., Uchida, W., Ogawa, T., Takeshige‐Amano, H., Hagiwara, A., Murata, S., Oyama, G., et al. (2020) · Journal of Neuroscience Research

Advanced Neuroimaging Techniques and ApplicationsParkinson's Disease Mechanisms and Treatments

Cited by 26

Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features

Ikeda, A., Shimada, H., Nishioka, K., Takanashi, M., Hayashida, A., Li, Y., Yoshino, H., Funayama, M., Ueno, Y., Hatano, T., et al. (2019) · Movement Disorders

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 22